Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AUTL	AUTOLUS THERAPEUTICS PLC	$353.97M	-63.80%	-30.90%	-40.97%	-28.80%	1.49	6.19	-61.20%	-439.70%	-463.91%
ACRV	ACRIVON THERAPEUTICS INC	$58.89M	-57.20%	-51.10%	-68.31%	-76.70%	0.15	7.69	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$9.07M	-1,172.90%	-162.10%	-286.88%	-194.80%	-3.05	3.58	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.30B	-688.90%	-158.00%	-219.78%	-196.70%	7.67	3.18	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$122.54M	-57.20%	-52.80%	-65.37%	-217.00%	0.09	11.73	N/A	N/A	N/A
ARVN	ARVINAS INC	$698.45M	-14.30%	-9.30%	-13.99%	-13.40%	0.66	4.92	100.00%	-30.80%	-30.65%
IONS	IONIS PHARMACEUTICALS INC	$12.01B	-68.90%	-12.30%	-10.54%	-7.90%	6.21	3.83	98.30%	-40.40%	-30.63%
NRIX	NURIX THERAPEUTICS INC	$1.59B	-57.50%	-43.80%	-43.83%	-59.10%	0.28	7.02	100.00%	-314.90%	-314.00%
WVE	WAVE LIFE SCIENCES LTD	$2.32B	-85.70%	-57.50%	-37.61%	800.30%	0.22	6.47	100.00%	-478.30%	-478.33%
PCVX	VAXCYTE INC	$8.05B	-25.90%	-23.80%	-27.41%	-26.70%	0.12	7.91	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$1.24B	-42.90%	-38.70%	-33.73%	-48.00%	0.12	9.95	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$1.98B	-41.20%	-38.40%	-45.35%	-55.20%	0.09	14.67	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$613.34M	-1,065.50%	-76.50%	-427.19%	-93.50%	-5.67	0.22	41.00%	-615.30%	-569.48%
FULC	FULCRUM THERAPEUTICS INC	$464.87M	-30.20%	-28.50%	-21.20%	-42.40%	0.05	27.40	N/A	N/A	N/A
LITS	LITE STRATEGY INC	$43.63M	-68.90%	-67.50%	-48.50%	-91.70%	0.01	10.04	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$37.86M	-144.40%	-71.70%	-109.10%	-184.00%	1.69	3.87	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$82.44M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$12.10M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.27B	-157.00%	-113.40%	-115.42%	-227.10%	0.58	5.61	100.00%	-3,777.40%	-3,704.89%
RGNX	REGENXBIO INC	$436.65M	-103.10%	-37.80%	-44.45%	-27.00%	3.41	2.38	88.10%	-113.80%	-87.34%
QNRX	QUOIN PHARMACEUTICALS LTD	$13.61M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$552.51M	N/A	-18.80%	-22.49%	-28.20%	-0.03	9.13	100.00%	-7,725.20%	-7,678.39%
ATOS	ATOSSA THERAPEUTICS INC	$46.67M	-49.40%	-44.80%	-60.62%	5,857.40%	0.17	6.77	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$70.75M	-341.30%	-174.10%	-266.08%	1,085.50%	0.86	2.52	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$2.87B	-59.70%	-49.10%	-42.87%	-56.70%	0.22	13.64	N/A	N/A	N/A
ACET	ADICET BIO INC	$65.35M	-83.00%	-68.00%	-68.36%	-87.70%	0.21	7.47	N/A	N/A	N/A
AARD	AARDVARK THERAPEUTICS INC	$77.23M	-44.60%	-41.50%	-54.01%	-60.50%	0.10	10.61	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.39B	-32.80%	-30.20%	-27.03%	-35.40%	0.09	21.94	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$284.38M	-37.50%	-35.10%	-28.67%	-42.40%	0.08	14.23	97.80%	-430.30%	-427.62%
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$3.04M	N/A	-1,490.10%	158.11%	923.80%	-1.21	0.17	45.50%	-1,056,755.00%	-933,320.14%
SMMT	SUMMIT THERAPEUTICS INC	$13.91B	-296.80%	-251.00%	-159.19%	-794.50%	0.14	9.87	N/A	N/A	N/A
RZLT	REZOLUTE INC	$304.32M	-64.80%	-59.40%	-65.24%	-83.90%	0.08	14.18	N/A	N/A	N/A
SNTI	SENTI BIOSCIENCES INC	$23.16M	-197.70%	-63.10%	-117.03%	-75.10%	5.49	1.51	N/A	N/A	N/A
MDWD	MEDIWOUND LTD	$217.94M	-65.80%	-30.20%	-35.10%	-60.20%	0.98	2.33	19.20%	-140.80%	-125.30%
TARA	PROTARA THERAPEUTICS INC	$287.19M	-36.40%	-33.80%	-28.93%	-48.70%	0.07	14.58	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$755.22M	-102.60%	-39.60%	-44.55%	-53.20%	3.24	6.06	99.90%	-412.90%	-410.27%
PHGE	BIOMX INC	$7.79M	-274.00%	-125.20%	5,947.65%	-207.00%	-5.44	0.87	N/A	N/A	N/A
KRRO	KORRO BIO INC	$157.49M	-115.90%	-71.30%	-114.82%	-73.40%	1.21	6.90	100.00%	-1,834.50%	-1,824.52%
GUTS	FRACTYL HEALTH INC	$79.32M	N/A	-148.10%	-136.75%	-172.70%	11.84	4.78	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$2.11B	-41.70%	-38.90%	-48.64%	-45.00%	0.11	10.49	100.00%	-16,748.00%	-16,748.03%
GOVX	GEOVAX LABS INC	$1.78M	-489.70%	-325.80%	-515.77%	27,088.00%	0.37	3.57	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$200.67M	-29.10%	-22.00%	-28.02%	-162.50%	0.27	6.64	100.00%	-80.20%	-80.19%
VOR	VOR BIOPHARMA INC	$134.71M	N/A	-1,545.90%	-1,556.28%	-10,196.70%	-1.08	9.16	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$30.50M	-261.90%	-150.80%	-249.87%	1,140.10%	3.97	2.59	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$150.14M	-204.10%	-121.40%	-164.57%	-330.20%	0.94	4.39	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$62.95M	-159.40%	-133.50%	-165.39%	28,750.00%	0.25	5.80	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$486.17M	-137.70%	-101.40%	-204.42%	-226.30%	0.87	2.19	N/A	N/A	N/A
EYPT	EYEPOINT INC	$1.09B	-88.30%	-72.50%	-70.85%	-104.10%	0.19	8.88	93.40%	-739.40%	-738.42%
CADL	CANDEL THERAPEUTICS INC	$365.50M	-51.40%	-36.30%	-31.04%	-354.50%	1.41	13.49	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$252.16M	53.20%	35.80%	39.49%	67.10%	0.38	6.93	73.70%	1,223.10%	1,289.05%
OSTX	OS THERAPIES INC	$50.71M	N/A	-278.90%	-380.14%	550.60%	1.17	0.56	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$1.29B	-68.00%	-50.90%	-58.70%	-126.40%	0.39	9.27	N/A	N/A	N/A
FRMM	FORUM MARKETS INC	$63.98M	-199.50%	-89.30%	-23.60%	-96.60%	1.27	10.07	100.00%	-5,671.90%	-5,476.00%
SPRY	ARS PHARMACEUTICALS INC	$784.45M	-100.30%	-51.10%	-58.50%	-47.60%	1.87	7.28	75.80%	-203.30%	-200.26%
VKTX	VIKING THERAPEUTICS INC	$3.84B	-48.00%	-45.70%	-56.28%	-54.10%	0.12	9.33	N/A	N/A	N/A
HELP	CYBIN INC	$237.00M	-65.60%	-55.90%	-48.03%	-428.20%	0.06	13.78	N/A	N/A	N/A
CRVO	CERVOMED INC	$37.41M	-96.00%	-82.90%	-147.98%	-142.30%	0.26	4.91	100.00%	-673.10%	-673.06%
SKYE	SKYE BIOSCIENCE INC	$20.86M	-143.60%	-119.90%	-278.09%	-354.00%	0.41	3.30	N/A	N/A	N/A
DCOY	DECOY THERAPEUTICS INC	$3.59M	-401.00%	-155.80%	-117.81%	443.70%	0.44	3.28	N/A	N/A	N/A
CMMB	CHEMOMAB THERAPEUTICS LTD	$11.89M	-82.40%	-71.80%	-72.93%	-234.10%	0.12	9.08	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$67.76M	N/A	N/A	N/A	N/A	-1.55	1.89	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$8.17M	-22.60%	-18.00%	-6.06%	-9.70%	0.43	12.33	N/A	N/A	N/A
AEON	AEON BIOPHARMA INC	$12.08M	N/A	0.00%	-0.59%	0.00%	-1.44	0.90	N/A	N/A	N/A
CLRB	CELLECTAR BIOSCIENCES INC	$12.51M	-282.30%	-146.90%	-213.04%	782.90%	0.59	2.96	N/A	N/A	N/A
SGMO	SANGAMO THERAPEUTICS INC	$118.11M	-814.00%	-116.50%	-283.90%	-311.60%	13.20	0.88	100.00%	-331.30%	-332.63%
SPRC	SCISPARC LTD	$252.45k	396.50%	155.80%	13,168.14%	557.40%	-6.68	0.55	42.30%	1,312.80%	1,434.74%
CRIS	CURIS INC	$27.99M	N/A	-26.10%	-128.73%	103.70%	2.66	0.49	99.50%	-80.30%	-80.29%
GRML	GREENLAND MINES LTD	$25.39M	-201.60%	-171.30%	-75.16%	3,177.10%	0.02	83.69	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$20.53M	-74.10%	-63.30%	-95.37%	-214.70%	0.09	12.53	100.00%	-4,646.10%	-4,645.44%
IMNN	IMUNON INC	$8.54M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$14.89M	-129.70%	-89.80%	-113.33%	-329.90%	0.36	5.78	N/A	N/A	N/A
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$0.00	-1,550.20%	-33.30%	-59.40%	-27.70%	0.51	0.71	-147.00%	-387.90%	-503.40%
BOLT	BOLT BIOTHERAPEUTICS INC	$8.65M	-92.50%	-47.10%	-69.08%	-47.00%	1.14	3.59	100.00%	-433.70%	-433.74%
CYCN	CYCLERION THERAPEUTICS INC	$6.36M	-24.60%	-22.40%	-23.06%	-41.30%	0.09	5.78	100.00%	-77.00%	-77.02%
CSBR	CHAMPIONS ONCOLOGY INC	$80.54M	-58.00%	-7.50%	-30.08%	-54.80%	5.62	0.98	45.90%	-3.90%	-4.03%
BOLD	BOUNDLESS BIO INC	$25.32M	-49.70%	-33.40%	-40.27%	-29.50%	0.59	8.74	N/A	N/A	N/A
VALN	VALNEVA SE	$562.27M	-74.50%	-25.60%	-23.64%	-19.60%	2.76	2.38	38.70%	-66.00%	-41.35%
XCUR	EXICURE INC	$29.38M	-108.80%	-52.90%	-73.84%	-897.50%	1.20	1.96	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$20.00M	N/A	-82.70%	-183.21%	165.90%	9.76	1.18	-44.70%	30,568.80%	30,568.80%
BCAB	BIOATLA INC	$9.29M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-244.80%	-171.40%	-217.16%	-1,804.70%	0.30	3.63	100.00%	-3,171.60%	-3,445.89%
CELU	CELULARITY INC	$34.28M	N/A	-66.40%	-149.15%	-98.10%	-6.69	0.16	50.60%	-198.90%	-179.83%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$2.21B	-23.40%	-20.70%	-24.43%	-29.50%	0.15	8.02	89.10%	-67.80%	-69.10%
SER	SERINA THERAPEUTICS INC	$32.31M	-1,259.20%	-213.60%	-511.98%	6,493.10%	6.15	1.31	100.00%	-16,022.40%	-15,994.83%
BLRX	BIOLINERX LTD	$12.43M	-6.00%	-2.80%	0.36%	3.50%	0.97	1.95	80.50%	-99.60%	8.90%
ADXN	ADDEX THERAPEUTICS LTD	$5.12M	-78.30%	-67.70%	-98.97%	-114.30%	0.23	2.01	100.00%	-3,845.80%	-3,843.07%
AKTX	AKARI THERAPEUTICS PLC	$9.79M	-68.40%	-31.90%	-55.39%	105.10%	1.00	0.19	N/A	N/A	N/A
ENSC	ENSYSCE BIOSCIENCES INC	$1.98M	-386.70%	-231.40%	-1,251.60%	-3,949.50%	1.92	1.27	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$25.78M	-165.20%	-77.80%	-89.65%	-761.70%	0.60	2.74	100.00%	-96.90%	-93.73%
BIVI	BIOVIE INC	$9.88M	-82.20%	-73.20%	-89.33%	9,178.80%	0.17	7.25	N/A	N/A	N/A
APLM	APOLLOMICS INC	$19.72M	-380.10%	-136.50%	-4,767.85%	1,243.90%	-3.53	0.97	100.00%	-366.90%	-362.92%
XBIT	XBIOTECH INC	$71.95M	-27.80%	-26.70%	-31.81%	-224.60%	0.07	16.01	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$34.17M	-118.70%	-102.00%	-125.99%	1,317.70%	0.16	0.90	N/A	N/A	N/A
RNAZ	TRANSCODE THERAPEUTICS INC	$7.83M	-685.60%	-319.80%	-1,200.88%	3,205.40%	2.67	1.60	N/A	N/A	N/A
CDT	CDT EQUITY INC	$707.16k	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
DYAI	DYADIC INTERNATIONAL INC	$31.59M	-537.20%	-78.10%	-90.29%	-119.30%	3.48	2.85	31.50%	-219.90%	-205.87%
AIXC	AIXCRYPTO HOLDINGS INC	$6.61M	-90.50%	-65.20%	-19.08%	-420.70%	0.13	8.83	N/A	N/A	N/A
PULM	PULMATRIX INC	$7.74M	-97.00%	-88.50%	-135.49%	1,843.60%	0.09	12.55	N/A	N/A	N/A
REVB	REVELATION BIOSCIENCES INC	$4.39M	-223.80%	-175.90%	-93.00%	839.40%	0.31	5.41	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$33.69M	-151.70%	-52.30%	-70.16%	1,172.70%	3.07	7.96	100.00%	-38,443.30%	-38,443.33%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.